Open Access<p>Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis</p>
Author(s) -
Chen Chen,
Xiaoping Li,
Jiazhi Jiang,
Shenjuan Li,
Gang Wang,
Lingao Ju,
Xinghuan Wang,
Tongzu Liu
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s243452
Subject(s) - bladder cancer , biomarker , cancer , cancer research , dna methylation , medicine , methylation , downregulation and upregulation , oncology , tissue microarray , microarray , gene , biology , gene expression , biochemistry
Bladder cancer is one of the leading causes of cancer death all over the world, and half of patients are diagnosed at advanced stages with poor therapeutic response. Thus, developing new biomarkers for bladder cancer diagnosis and prognosis is urgently needed.